Operating Expenses

R&D

General Mills R&D remained flat by 0.0% to $64.15M in Q1 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.5%, from $64.45M to $64.15M. Over 4 years (FY 2021 to FY 2025), R&D shows relatively stable performance with a 1.8% CAGR.

Analysis

StatementIncome Statement
SectionOperating Expenses
CategoryGrowth
SignalContext dependent
VolatilityModerate
First reportedQ1 2021
Last reportedQ4 2025Jun 26, 2025

How to read this metric

Higher spending signals a commitment to innovation and future product launches, whereas significant cuts may indicate a shift toward short-term profitability.

Detailed definition

Research and development expenses represent the costs incurred to discover new products, improve existing technologies,...

Peer comparison

Highly comparable across pharmaceutical and medical device peers, where R&D intensity is a key metric for long-term valuation.

Metric ID: research_and_development

Historical Data

5 years
 FY'21FY'22FY'23FY'24FY'25
Value$239.30M$243.10M$257.60M$257.80M$256.60M
YoY Change+1.6%+6.0%+0.1%-0.5%
Range$239.30M$257.80M
CAGR+1.8%
Avg YoY Growth+1.8%
Median YoY Growth+0.8%

Frequently Asked Questions

What is General Mills's r&d?
General Mills (GIS) reported r&d of $64.15M in Q1 2025.
How has General Mills's r&d changed year-over-year?
General Mills's r&d decreased by 0.5% year-over-year, from $64.45M to $64.15M.
What is the long-term trend for General Mills's r&d?
Over 4 years (2021 to 2025), General Mills's r&d has grown at a 1.8% compound annual growth rate (CAGR), from $239.30M to $256.60M.
What does r&d mean?
The money spent on creating new products or improving existing ones to drive future growth.